HOME >> BIOLOGY >> NEWS
Joslin Diabetes Center launches research section on developmental and stem cell biology

joined Joslin from the laboratory of world-renowned stem cell researcher Irving Weissman, M.D., at Stanford University School of Medicine. She is studying the migration and function of blood-forming stem cells, which are capable of regenerating the entire blood system and one of the only types of stem cells currently used through bone marrow transplantation for the treatment of human diseases (including leukemia, lymphoma, immune deficiency and others). Transplantation of blood-forming stem cells may also be used someday to help people with diabetes, either by aiding in blocking the autoimmune process that causes type 1 diabetes, or by allowing patients to better tolerate islet transplants without the need for prolonged use of powerful immunosuppressive drugs.

In related studies, using strategies that previously have been successful in identifying precursor cells in the blood system, Dr. Wagers also is working to identify additional tissue-specific adult stem cell populations in bone marrow, skeletal muscle, the heart and the pancreas that may function robustly to regenerate or repair damaged adult tissues. The identification of such cells may have important implications for treating many of the long-term complications of diabetes. In addition, this comprehensive analysis of adult stem cell developmental potential will provide insights into the fundamental principles and limitations guiding adult stem cell function, and may ultimately suggest new treatment options for multiple degenerative disorders.

Birth Defects in the Offspring of Women with Diabetes Targeted

Long-time Joslin researcher Mary Loeken, Ph.D., who transferred from the Section on Cellular and Molecular Physiology, is studying the underlying causes of birth defects in diabetic pregnancy. Dr. Loeken and her colleagues have found that birth defects, which occur two to five times more frequently in the pregnancies of women who have diabetes, result from failure to induce
'"/>

Contact: Marjorie Dwyer
marjorie.dwyer@joslin.harvard.edu
617-732-2415
Joslin Diabetes Center
11-Aug-2004


Page: 1 2 3 4 5 6

Related biology news :

1. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
2. Joslin researchers clarify mechanisms for beta-cell formation
3. Joslin President awarded medal from international diabetes organization
4. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
5. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
6. Joslin Diabetes Center releases new low impact exercise video
7. Joslin researchers identify key molecule in Type 1 diabetes progression
8. As obesity skyrockets, Joslin Diabetes Center urges action to stem the tide of type 2 diabetes
9. Diabetes drug may be new tool in treating breast cancer
10. Diabetes in the elderly linked to fewer cellular power plants
11. Diabetes therapies and liquid memory may develop from micro fluid research, Science researchers say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 28, 2020 , ... ... for adjunct liquefaction: AMYLEX® 6T. The innovative enzyme enables numerous business gains ... segments with locally-sourced raw materials, improve productivity, maximize yield, ensure consistent quality ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company ... cell engagers and TCR-based therapeutics, has implemented Genedata Biologics ® within ...
(Date:5/21/2020)... Ga. (PRWEB) , ... May ... ... of Human Capital IntegritySM technology-based services specializing in background and medical screening, ... their COVID-19 return-to-work planning and keeping their workforce safe. The new service ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 29, 2020 , ... ... competitively procured purchasing contracts to its membership, recently named BioFit Engineered Products ... with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts ...
(Date:6/28/2020)... LAGUNA NIGUEL, Calif. (PRWEB) , ... June 25, 2020 , ... ... today announced the launch of Safe Space™ for businesses of all types to ensure ... and 3D LiDAR. , A Safe Space™ enabled business will provide a ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for treating cancer, today announced the company has entered a license agreement with ... agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a ...
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast Inc. ... materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research ... enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety ...
Breaking Biology Technology:
Cached News: